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Abstract: Taurine (TAU) is a sulfur-containing beta amino acid that is not involved in protein
composition and anabolism, conditionally essential in mammals provided through diet. Growing
evidence supports a protective role of TAU supply in osmoregulation, calcium flux, and reduction
of inflammation and oxidant damage in renal diseases like diabetes. Endoplasmic reticulum
(ER) stress, due to abnormal proteostasis, is a contributor to nephrotic syndrome and related
renal damage. Here, we investigated the effect of dietary TAU (1.5% in drinking water for
15 days) in an established rat model that mimics human minimal change nephrosis, consisting
of a single puromycin aminonucleoside (PAN) injection (intraperitoneally 15 mg/100 g body weight),
with sacrifice after eight days. TAU limited proteinuria and podocytes foot processes effacement,
and balanced slit diaphragm nephrin and glomerular claudin 1 expressions. In cortical proximal
tubules, TAU improved lysosomal density, ER perimeter, restored proper ER-mitochondria tethering
and mitochondrial cristae, and decreased inflammation. Remarkably, TAU downregulated glomerular
ER stress markers (GRP78, GRP94), pro-apoptotic C/EBP homologous protein, activated caspase
3, tubular caspase1, and mitochondrial chaperone GRP75, but maintained anti-apoptotic HSP25.
In conclusion, TAU, by targeting upstream ER stress separate from mitochondria dysfunctions at
crucial renal sites, might be a promising dietary supplement in the treatment of the drug-resistant
nephrotic syndrome.
Keywords: apoptosis; endoplasmic reticulum stress; kidney; puromycin aminonucleoside;
taurine; ultrastructure
1. Introduction
Nephrotic syndrome, which is one of the most widespread renal disorder in humans [1], includes
a wide spectrum of diseases, with an idiopathic, toxic, or immunologic etiology, which is classified
into four histological variants: minimal change disease (MCD), focal segmental glomerulosclerosis
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(FSGS), membranous nephropathy, and collapsing glomerulopathy, with different sensitivities to
glucocorticoids [2]. MCD is the major idiopathic syndrome in children below one year of age,
where corticosteroids, mainly prednisolone, are the choice treatment to ensure rapid remission [3].
Unfortunately, relapse occurs and a second line immunosuppressant with severe side effects may
be necessary. In adults, MCD may progress into steroid-resistant FSGS [4–6]. However, an effective
treatment to stop MCD recurrence and progression to end-stage damage is still debated in the scientific
community along with its pathogenesis [7].
Puromycin aminonucleoside (PAN), which is an analogue of puromycin antibiotic, has been
largely adopted to experimentally induce MCD in rodents (with a single high dose) [8] or FSGS (by
repeated doses for over a longer period) [9]. Proteinuria is a common adverse event in primary
podocytopathies due to the deranged filtration barrier that contributes to renal inefficiency [10].
Podocytes are terminally differentiated cells that are found in the visceral layer of the Bowman capsule,
with pedicels separated by slit diaphragms, essential for pore formation [11]. PAN is a dose-dependent
toxin for the podocytes induction of pedicels disorganization that is associated with in vivo and in vitro
proteinuria [12].
Slit diaphragms in podocytes contain peculiar cytoskeletal proteins, like nephrin, podocin,
and synaptopodin, regulated by actin and are essential for filtration [13]. In particular, nephrin,
which is the main slit diaphragm glycoprotein, prevents the endoplasmic reticulum (ER) from being
glycosylated, so ensuring permeability [14]. In contrast, abnormal nephrin traffic in slit diaphragms
leads to heavy proteinuria [15]. Similar effects were linked to aberrant junctional claudin 1 in the
glomeruli of transgenic mice and rats that were treated with PAN [16]. Moreover, in normal podocytes,
the actin dynamic is modulated by calcium ions, but detrimental regulation of calcium based on
calpain and calcineurin proteases occurred in PAN nephrosis [17,18].
Remarkably, calcium signaling and a proper balance between the secreted and misfolded proteins
are key functions of the ER [19–21]. A strong relationship exists between proteinuria, renal damage
and disrupted ER activity, called “ER stress”, and the unfolded protein response (UPR) [22].
Several papers outlined the main role of ER stress in the progression of acute and chronic kidney
injury and diabetes in experimental models [23–25]. In MCD patients, ER stress was found to trigger
tubule-interstitial fibrosis and inflammation linked to heavy proteinuria [26].
A key event in the UPR is the upregulation of resident ER chaperones glucose regulated protein
78 (GRP78, immunoglobulin heavy chain-binding protein, BiP), glucose-regulated protein 94 kDa
(GRP94, also known as endoplasmin), and calreticulin and calbindin, which are all able to activate
three molecular cascades to restore homeostasis [27,28]. However, if renal ER stress persists, apoptosis
is triggered by mediators like C/EBP homologous protein (CHOP or GADD153) [29].
Heat shock proteins (HSPs) are highly conserved proteins that are involved in the maintenance
of renal proteostasis in response to heat, hormones, drugs, heavy metals and ischemia [30,31].
HSPs include seven families, which are based on their common molecular weight, often essential
for apoptosis regulation [32]. HSP25—in rodents (HSP27 in humans)—is a small HSPs member
that protects actin cytoskeleton in podocytes foot processes and limits apoptosis during in vivo and
in vitro PAN nephrosis [33,34]. GRP75 (also called mortalin or mthsp70), a member of HSP70 family,
is predominant in mitochondria where it recovers respiratory enzymes during oxidative damage [35].
The kidney, which is only second to the heart in terms of mitochondria abundance, strongly adopts
oxidative metabolism for hemodynamic and glomerular filtration [36,37]. In nephrotic syndrome
and in the experimental PAN model, mitochondrial damage, reduced ATP production, and increased
reactive oxygen species (ROS) have been reported [38,39].
Taurine (TAU) is a semi-essential beta amino acid present up to 0.1% in the human body,
endogenously synthesized by cysteine, but is mainly introduced by a diet rich in sea-food
and poultry [40]. TAU is necessary for the proper development of the infant brain, retina,
and cardiac health [41] TAU transporter knockout mice exhibited overt oxidative damage, ER stress,
and apoptosis [42]. A promising therapeutic role for TAU supplementation in metabolic diseases,
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like heart failure, diabetes, and muscle and inflammatory diseases, in rodent models but also in
humans, has been recently reported by Schaffer and Kim [43]. TAU has also been rediscovered for the
treatment of renal infections, nephrolithiasis and diabetes [44–47], but to the best of our knowledge,
its role in acute PAN nephrosis is limited to a biochemical study by Venkatesan et al. [48].
Therefore, we completed this study to explore if ER stress in parallel to mitochondrial damage in
podocytes and epithelial tubular cells can be potential targets for TAU in experimental PAN nephrosis
in rats.
Our results outlined a novel therapeutic role for TAU dietary supplementation against ER stress
and for mitochondria-driven events, like apoptosis and inflammation, in experimental PAN nephrotic
syndrome coupled to massive proteinuria.
2. Materials and Methods
2.1. Chemicals
Puromycin aminonucleoside was purchased by Sigma Aldrich (St. Louis, MO, USA).
For monitoring urinary proteinuria, Multistix 10 SG Reagent Strips-Bayer was purchased by Siemens
Healthcare Diagnostics (Milan, Italy). Histological stains for PAS, sodium metabisulphite, periodic
acid and Harris or Mayer’s hematoxylin were of the highest grade (Sigma Aldrich, St. Louis,
MO, USA). For immunohistochemistry, we purchased from Abcam (Cambridge, UK) monoclonal
anti-CD68/ED1 (ab31630), polyclonal 4 hydroxy-2-nonenal (4HNE) (ab46545); polyclonal anti-caspase
3 activated (ab4051) and polyclonal anti-GRP78 (ab21685). From Sigma Aldrich (St. Louis,
MO, USA), we purchased polyclonal anti-claudin 1 (SAB4200462), from GeneTex (Irvine, CA,
USA) rabbit polyclonal anti-caspase 1-p10 (GTX123675) and from Santa Cruz Biotechnology, Inc.
(Dallas, Texas, USA), we purchased rabbit polyclonal antibody anti-GRP75 (sc-13967), polyclonal
anti-GADD153/CHOP (sc-575), goat polyclonal anti-HSP25 (sc-1049), goat polyclonal anti-nephrin
(sc-32530), and rat monoclonal antibody anti-GRP94 (sc-56399).
2.2. Animal Treatment
Twenty two-month-old male Sprague Dawley (SD) rats were purchased from Harlan Laboratories
Srl (San Pietro al Natisone, Udine, Italy). Animal care was performed according to the Italian Ministry
of Health to comply with the commonly-accepted international guidelines known as “3Rs” European
Community Council Directive 86/609/EEC.
SD rats were divided into the following four groups: (1) n = 4 SD rats fed standard rodent diet
and tap water (control group); (2) n = 4 SD rats fed standard diet but drinking taurine (TAU) dissolved
1.5% in tap water for 15 days (TAU group) [49]; (3) n = 6 SD rats fed normal standard diet and injected
with PAN (intraperitoneally injected; 15 mg/hg) (PAN group) [50] and (4) n = 6 SD rats fed standard
diet injected with PAN, but drinking TAU one week before and another week after PAN injection (PAN
plus TAU group). The rationale for two weeks of TAU supplementation was obtained from the study
of Moloney et al. [51], where this duration of treatment reversed early diabetic damage in patients.
The power analysis to define the number of animal for each group was evaluated by the Student
t test with a significance of 0.05. All animals were sacrificed by cervical dislocation on day 8 after
PAN injection, and the kidneys were removed for histopathology, immunohistochemical, and electron
microscopy analysis. A similar approach was successful to best analyze stress response in the kidney
in a previous study [52]. Proteinuria was measured at day 8 after PAN injection in 16 h collected urine
samples during overnight placement in metabolic cages. Urinary parameters were assessed using
Multistix 10SG Reagent Strips and the animals were considered to have a severe proteinuria following
three consecutive readings >300 mg/dL [53].
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2.3. Histopathology and Immunohistochemistry
For histopathology, the kidneys were fixed for immersion in 4% phosphate buffered
paraformaldehyde for 48 h and were embedded in paraffin wax, as previously reported [54]. Paraffin
sections (5 µm-thick) were prepared for PAS staining and immunohistochemistry. For quantitative
analysis of glomerular tuft area, PAS stained renal sections were observed at a final magnification
of 400× using a light microscope (Olympus, Hamburg, Germany) and at least 25 glomeruli for
four different slides were randomly analyzed for each experimental group. The glomerular area
was manually traced and estimated using imaging software (Image Pro Plus, Milan, Italy) by two
investigators in a blinded manner. On the same section, also renal tubular-interstitial damage was
also assessed on 10 non-overlapping fields at 200× and four different slides for each experimental
group were randomly chosen. Normal cortical proximal tubules presented an epithelium with a
single layer of cubic cells showing a purple PAS-positive brush border (consisting of microvilli during
ultrastructural analysis) and a central nucleus, but these findings were lost in damaged tubules.
Tubular atrophy, epithelial disruption, and protein casts were semi-quantitatively graded, as follows:
grade 0, normal; grade 1, lesion area <25% of the field; grade 2, lesion area between 25% and 50% of the
field; grade 3, lesion area between 51% and 75% of the field; and, grade 4, >75% lesion area. Tubular
injury score represented the average of the grades that are assigned to the fields analyzed. The main
changes examined include tubular atrophy, tubular casts, sloughing of tubular epithelial cells, and the
presence of inflammatory cells, as previously reported by He et al. [55]. Serial paraffin sections were
used for immunohistochemistry, dewaxed in xylene, rehydrated and subjected to antigen retrieval
in 0.01 M citrate buffer (pH 6.0) in a microwave oven, and then treated in 3% hydrogen peroxide to
block the endogenous peroxidase background. Slides were treated with normal serum of the same
species producing the secondary antibody (diluted 1:5) for 1 h at room temperature in the dark and
subsequently incubated, overnight at 4 ◦C in humidified chambers, with: rabbit polyclonal anti-GRP75
(diluted 1:200); rat monoclonal anti-GRP94 antibody (diluted 1:200); goat polyclonal anti-CHOP,
anti-HSP25 and anti-nephrin antibodies (diluted 1:50-1:100-1:50 respectively), rabbit polyclonal
anti-GRP78, anti-caspase3 and anti-caspase 1-p10 antibodies (diluted 1:250 and 1:50 respectively),
mouse monoclonal anti-CD68/ED1 antibody (diluted 1:200); and, rabbit polyclonal 4HNE(diluted
1:400). Viewing was performed using the avidin-biotin-peroxidase complex (ABC-peroxidase kit,
Vector Labs, Burlingame, CA, USA), according to manufacturer’s instructions. The peroxidase reaction
was developed using 3′-3′-diminobenzidine tetrahydrochloride (Sigma Aldrich, St. Louis, MO,
USA) as the substrate and hydrogen peroxide as the catalyst for 7 min in the dark. To assess the
specificity of each immunoreaction, we omitted primary antibodies and substituted those with tris
buffered solution. All sections were counterstained by hematoxylin, dehydrated and mounted for light
microscopy analysis (Olympus, Hamburg, Germany). Then, an immunopositive area was quantified
at 400× using computerized image analysis software (Image Pro Plus, Milan, Italy), as follows:
brown peroxidase-positive area for each field was manually circled, then automatically converted
into a gray-scale pixel to obtain a total value as arbitrary value (AU). Twenty randomly chosen
non-overlapping fields for each immunostaining were estimated. In particular, for the quantification
of nuclear markers, nuclei that were further stained with haematoxylin appeared blue-violet and were
not estimated by the software set on brown color.
2.4. Transmission Electron Microscopy
The second kidney was fragmented in small pieces and was fixed for immersion in 2.5%
glutaraldehyde in cacodylate buffer 0.1 M for 3 h then post-fixed in 2% osmium tetroxide in the
same buffer for 1 h at 4 ◦C. Dehydration in progressive ethanol concentrations, propylene oxide,
and embedding in Epon 812 mixture were performed, as previously described [56].
Semithin sections (1 µm thick) obtained with an UltraCut E ultra-microtome were then stained
by methylene blue-azure II, and then observed under a light microscope to verify the presence of
lysosomes at 100×. Subsequently, thin sections (80 nm thick) collected on cupper grids were observed
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under a transmission electron microscope Tecnai G2 Spirit (FEI Company, Eindhoven, The Netherland)
at 80 kV. Morphometric computerized analysis of foot processes of podocytes was performed at
15,000×, but the ER perimeter was estimated at 26,000×, and ER-mitochondria distance at 135,000×
by two observers blinded of the treatment, as previously described [57].
2.5. Statistical Analysis
All data are expressed as mean ± standard deviation and analysis of the statistical significance
was obtained using one-way analysis of variance (ANOVA) corrected by Bonferroni test to compare
the variability of a group with all the other experimental groups and p < 0.05 being considered to be
significant. All of the experiments were performed in triplicate, and data were collected and analyzed
by Origin Pro 9.1 software (Origin Lab Corporation, Northampton, MA, USA).
3. Results
3.1. Metabolical and Histopathological Effects of TAU in Nephrotic Rats
Similar metabolic and histological data were recorded in the control and TAU only treated
rats, so they are labelled the “control group” in the next described evaluation. Metabolic and
urinary parameters are summarized in Table 1. PAN-treated rats developed massive proteinuria
(1200 ± 130 mg/dL) compared with the control group in which proteinuria was undetectable.
However, in the TAU supplemented PAN group, proteinuria significantly decreased to a low range
(80 ± 22 mg/dL). Urinary volume tripled in PAN nephritic rats, but significantly decreased in the
TAU supplemented PAN group. Urinary leukocytes were absent in the control group, abundant in
PAN group (125/dL), and decreased after PAN plus TAU treatment (70/dL) (all p < 0.05). To further
corroborate the role of TAU preconditioning in the PAN model, the renal expression of the lipid
peroxidation marker 4HNE was analyzed and quantified (Figure S1).
Table 1. Metabolic and urinary data of puromycin (PAN) nephrotic rats with either taurine (TAU) or
no TAU treatment.
Control
(N = 4)
Taurine
(N = 4)
PAN
(N = 6)
PAN + Taurine
(N = 6)
Body weight (g) 248.5 ± 10.0 240.8 ± 10.0 200.6 ± 12.00 * 230.5 ± 10.0 **
Urinary Volume (mL/day) 5.5 ± 0.9 5.3 ± 0.9 18.8 ± 10.0 * 9.5 ± 8.5 **
Proteinuria ND ND 3+ 1+
Urobilinogen (mg/dL) 0.2 0.2 0.2 0.2
Hemoglobin (mg/dL) 0.025 0.025 0.025 0.025
Leukocytes (N/dL) absent absent 125 (2+) 70 (2+)
Note: Values are means ± SD, * p < 0.05 versus control and taurine groups, ** p < 0.05 versus PAN group; 24 h urine
was analyzed by MULTISTIX 10SG reagent strips (Bayer). Proteinuria: ND, less than 15 mg/dL, (1+), 30–100 mg/dL;
(2+), 100–300 mg/dL, (3+), 300–2000 mg/dL, Glucose: ND less than 75 mg/dL; Ketones: ND less than 5 mg/dL in
all the groups; Urobilinogen: Normal value 0.2.
PAS staining did not reveal any damage to glomeruli, and similarly no differences in glomerular
area were observed in experimental groups (data not shown). These findings confirmed the hallmark
of “minimal change nephrosis” (MCD), i.e., absence of glomerular damage under light microscopy
analysis. So, we analyzed the filtration barrier by transmission electron microscopy, the elective
method that best defines proteinuria-induced changes in MCD patients [58]. In control rats, regular
podocytes’ foot processes adhered to the basal membrane and well-structured slight diaphragms were
visualized (Figure 1A,E). In contrast, in PAN-injected rats, prominent fusion of pedicels and tight
junctions between pedicels, together with limited slight diaphragms, were observed (Figure 1B,F).
In contrast, after TAU pre-treatment, more regular thin foot processes and recovered filtration slits
in the glomerular barrier were evident (Figure 1C,G). Estimation of foot processes width on electron
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micrographs demonstrated a significant enlargement in PAN-injected rats (750 nm) when compared
to the control group (200 nm), but a decreased width in the PAN supplemented with TAU group
(Figure 1D). These data indicated that TAU intake partially improved podocytes effacement in the
PAN-treated group. Slight diaphragms quantification significantly decreased by 42% in the PAN
group (p < 0.05), but increased by 21% in PAN plus TAU supplemented rats (Figure 1H). These values
indicated that TAU pre-treatment positively influenced the distribution of glomerular filtration sites.
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processes and the main component of a normal slight diaphragm, was highly expressed in control 
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group receiving TAU supplementation (Figure 2C). Estimation of nephrin staining intensity, as 
arbitrary units, was high in the control group, lower in the PAN group (p < 0.05), and then 
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In contrast, claudin 1, which is a tight junctional marker that is localized in the external 
epithelial layer of Bowman capsule, was barely detectable in the control group (Figure 2E), 
markedly expressed in PAN group (Figure 2F), and significantly reduced at the glomerular level in 
the PAN supplemented TAU group (Figure 2G). The immunoreaction was also quantified and the 
relative immunopositivity evaluation is summarized in Figure 2H. 
Figure 1. Podocyte damage. Dietary TAU reduced podocyte damage in PAN. Transmission electron
micrographs of glomerular podocytes in (A–E) control, (B–F) PAN-injected rats, or (C–G) with TAU
supplementation. In the PAN group, podocytes showed tight junctions (circled) together with pedicels
feet (p) fusion and reduced slit diaphragm number (arrow). These changes were improved by TAU
pre-treatment and were almost similar to control rats. (A–C) bar represents 1 µm and (D–F) bar
represents 500 nm. Quantitative analysis of (D) foot processes width and (H) slit diaphragm number.
Data are expressed as means or percentages. * p < 0.05 significant versus control group; ** p < 0.05
significa t versus PAN group.
3.2. TAU Changes Podocytes Markers Distributions in Nephrotic Rats
To confirm podocyte impairment using transmission electron microscopy, we explored the
glomerular localization of the cytoskeletal markers nephrin and claudin 1 to highlight the extent
of PAN nephrosis in different groups. Nephrin, which is a structural marker of podocyte foot processes
and the main component of a normal slight diaphragm, was highly expressed in control rats (Figure 2A),
diminished in PAN nephrotic rats (Figure 2B), was partially restored in the PAN group receiving TAU
supplementation (Figure 2C). Estimation of nephrin staining intensity, as arbitrary units, was high in
the control group, lower in the PAN group (p < 0.05), and then increased in the PAN group receiving
TAU (Figure 2D).
In contrast, claudin 1, which is a tight junctional marker that is localized in the external epithelial
layer of Bowman capsule, was barely detectable in the control group (Figure 2E), markedly expressed
in PAN group (Figure 2F), and significantly reduced at the glomerular level in the PAN supplemented
TAU group (Figure 2G). The immunoreaction was also quantified and the relative immunopositivity
evaluation is summarized in Figure 2H.
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3.4. TAU Decreases Tubular Apoptosis and Oxidative Damage
hile considering the crucial role of the first tract of the nephron in the reabsorption of excessive
urinary proteins, we extended immunohistochemical analysis of ER-driven apoptosis to proximal
cortical tubules. Occasional pro-apoptotic CHOP in the nuclei of the proximal tubules of control
rats (Figure 4A) was clearly expressed in disrupted proximal tubules in PAN-injected rats on day
eight (Figure 4B) and decreased in the PAN plus TAU group (Figure 4C). Accordingly, the percentage
of nuclear positivity shifted from 8% in control rats to 36% in the PAN group and to 18% in TAU
supplemented group (Figure 4D).
Caspase 3 is the crucial marker of the final step in the apoptotic cascade that must be activated by
proteolysis [59]. So, we evaluated the presence of cleaved caspase 3 in cortical renal tubules in our
model. Control rats did not express cleaved caspase 3 in the kidney (Figure 4E); in contrast, in the PAN
group, an intense nuclear staining was observed in the proximal tubules, but only occasionally in the
glomeruli on day eight (Figure 4F). After TAU pre-treatment, cleaved caspase 3 immunostaining was
limited to a few nuclei in the proximal tubules (Figure 4G). Quantitative analysis showed that nuclear
positivity for the cleaved activated caspase 3 was very low in control rats, 26 AU in the PAN group,
but decreased in rats that were receiving PAN and TAU (p < 0.05) (Figure 4H).
To best correlate the extent of apoptosis to oxidative damage, we visualized the renal distribution
of HSP25, an inducible actin chaperone able to oppose ATP-depletion in the kidney. Nuclear HSP25
expression was weak in the proximal tubules of the control rats (Figure 4I), and intense in the
PAN-treated group localized in the proximal and distal tubules (Figure 4L). In contrast, in PAN
nephrotic rats supplemented with TAU, the HSP25 signal shifted to the brush border in proximal
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tubules and to the cytoplasm of the distal tubules (Figure 4M). Quantitative analysis of HSP25
abundance confirmed the highest value in PAN-injected rats, which decreased by 50% after TAU
supplementation to a value that was not that different from the control (p < 0.05) (Figure 4N).
These results indicated that dietary TAU supplementation reduced tubular apoptosis and oxidative
damage in proximal tubules.
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Figure 4. Proximal tubular apoptosis. (A–C) CHOP, (E–G) activated caspase 3, (I–M) HSP25 in (A,E,I)
control rats, and (B,F,L) PAN nephrotic rats that decreased with oral TAU pre-treatment (C,G,M).
(M): the arrow shows the brush border positivity at proximal tubule level and the asterisks identify
the positivity in the distal tubules. Bar represents 20 µm. Quantitative analysis of immunostaining for
(D) CHOP, (H) expressed as nuclear positive percentage, and (N) for caspase 3 cleaved and HSP25,
expressed as arbitrary units. * p < 0.05 statistically significant versus control group; ** p < 0.05 significant
versus PAN group.
3.5. TAU Improves Tubular Inflammation and Mitochondrial Stress in PAN Nephrosis
In addition t apoptosis and ER tress, tubular inflammation and the interstitial recruitm nt
of macroph ges from circulation are also involved in the renal lesions that are induced by
acute proteinuria.
In our ne hritic model, the histological analysis of PAS stained cortical tubules revealed a regular
purple brush border i the control rats (Figure 5A), PAS st in proteinaceous casts in the lum n of the
PAN nephrotic group (Figure 5B), and enlarged dilated proxi al tubules in the PAN group receiving
TAU (Figure 5C). Semi-quantitative estimation of proximal tubular damage, expressed as a “tubular
score”, was 0.5 in control rats, significantly increased to 3.5 in nephrotic rats, and decreased to 2 AU in
PAN group pre-treated with TAU (Figure 5D).
Moreover, we decided to examine the tubular presence of activated caspase 1, a component of
NLRP3 inflammasome, which is the multiprotein complex sensitive to ER damage. The staining of
activated caspase 1, i.e., the subunit caspase 1-p10, was barely detectable in the proximal tubules
in control rats (Figure 5E), intense in the proximal tubules in the PAN-injected group (Figure 5F),
and weaker in the PAN rats that received TAU (Figure 5G). Quantitative analysis revealed that caspase1
p10 intensity was very low in the control group, dramatically increased 14 fold in PAN, but significantly
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decreased in the PAN plus TAU group, p < 0.05 (Figure 5H). Figure S1 shows the evaluation of the
CD68/ED1 macrophage infiltration in the tubule interstitial area.
Finally, to better understand the effect of different treatments on mitochondrial homeostasis,
we analyzed the expression of the mitochondrial chaperone GRP75. In control rats,
GRP75 immunoreaction was faint in the cytoplasm of the proximal tubules (Figure 5I), strong in
the damaged proximal tubules of the PAN nephrotic rats (Figure 5L), and limited to few epithelial
cells in the PAN rats supplemented with TAU (Figure 5M). Estimation of GRP75 immunostaining
tripled in the PAN group as compared with the control group, but halved in PAN rats that were
supplemented with TAU (value 18 AU; p < 0.05) (Figure 5N). Therefore, all of these data indicated that
TAU pre-treatment was effective against “sterile” inflammation and oxidative damage by modulating
caspase 1 activation and GRP75 abundance in proximal tubules.
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Figure 5. Tubular Inflammation and Mitochondrial Stress. (A–C) PAS histopathology, (E–G) activated
caspase 1-p10 and (I–M) mitochondrial chaperone GRP75 stainings in the proximal tubules of (A,E,I)
control rats, (B,F,L) PAN nephrotic rats and (C,G,M) PAN rats orally pre-treated with TAU. (A–C) The
arrows identify the proteinaceous casts and the asterisks show the tubular dilatation. Bar represents
20 µm. Tubular damage expressed as (D) tubular injury score, (H) quantitative estimation of caspase
1-p10, (N) and GRP75 immunostainings, expressed as arbitrary units. * p < 0.05 statistically significant
versus control group; ** p < 0.05 significant versus PAN group.
3.6. Effect of TAU on Mitochondria and Rough ER in Nephrotic Proximal Tubules
To understand whether TAU alleviation of tubular apoptosis and altered oxidative status that we
observed via immunohistochemistry may be correlated to the morphology of the ER, mitochondria,
or other organelles, we examined the proximal tubules using electron microscopy. At low magnification,
we observed scattered dense mitochondria and scarce lysosomes in the control group (Figure 6A),
excessive perinuclear lysosomes, and multiple rough ER (RER) cisternae in the PAN group (Figure 6B),
and elongated mitochondria in the PAN plus TAU supplemented group (Figure 6C). At high
magnification, we focused on mitochondria and RER features. In the control proximal tubules,
mitochondria displayed parallel cristae and a regular distance from RER (Figure 6D). In contrast, in the
PAN nephrotic group, the mitochondria contained a few short cristae, a disrupted outer membrane,
and were fused in multiple points with RER (Figure 6E). Remarkably, in the PAN rats that were
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supplemented with TAU, mitochondria presented restored cristae, well-defined outer membrane,
and regular RER distance that was similar to the control rats (Figure 6F).
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To best corroborate the above findings, lysosomal density, RER perimeter, and the distance
between ER and the outer mitochondrial membrane were measured. In proximal tubules of contr l
rats, lysosomal density w s 45 (expressed as number per 100 µm2), almost oubled (80) in PAN injected
rats, but decreased to the control level after TAU supplementation (48) (Figure 6G). I PAN-treated
rats, ER p rimeter significantly increased up to 120 µm/field in proximal tu ules when compared to
the control group (40 µm/field). After TAU pre-treatment, the ER perimeter was similar to that of
the control rats (44 µm/field) (Figure 6H). Furthermore, when considering the crucial role of ER and
mitochondria juxtaposition in regulating ER signaling [60], we estimated ER-mitochondria tethering
in our experimental model. The distance between organelles in control rats was less than 50 nm,
significantly decreased to 26 nm in the PAN-injected group, but was almost similar to the control value
in TAU supplemented PAN rats (43 nm) (all p < 0.05) (Figure 6I). These results indicated that TAU
inhibited mitochondrial alterations and it contributed to the maintenance of a proper distance between
mitochondria and RER in proximal tubules.
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4. Discussion
Proteinuria, which is the presence of proteins in urine, is not only a diagnostic marker of
glomerular damage but also a strong contributor to tubular decline and the progression of chronic
kidney disease [61,62]. ER stress and UPR are fundamental mechanisms that are involved in the
pathogenesis of proteinuric renal failure [25,63]. However, ER modulation by drugs may be of great
value for a nephrologist to develop effective personalized ER-targeted treatments in unresponsive
or recurrent nephrotic syndrome, instead of conventional glucocorticoids or immunosuppressive
drugs [7,64].
One major point addressed in this study was that TAU alleviated experimental PAN nephrosis
and proteinuria in rats by reducing ER stress and HSPs response.
Indeed, in rats, a single-dose PAN injection induced massive proteinuria on day eight, which was
associated with ultrastructural glomerular and tubular alterations, mimicking human MCD [48].
In rats, TAU preconditioning, one week before and another after PAN injection, decreased proteinuria
and renal damage. Through ultrastructural analysis, we clearly observed reduced podocyte effacement
in the TAU supplemented nephrotic animals, but an enhanced slit diaphragm number and distribution.
Furthermore, in agreement with morphological findings, TAU restored glomerular nephrin, which is
the main slit diaphragm component, and minimized claudin 1 in our nephrotic model.
Notably, claudin 1 in nephrotic glomeruli was correlated with the presence of tight junctions,
and it indicated a dysfunctional filtration barrier able to promote proteinuria in line with the findings
that were reported by Gong et al. [16]. However, in this study, we demonstrated that TAU dietary
supplementation restored proper expressions of these two markers in the PAN nephrotic model.
In vitro studies on malignant cells reported that PAN induced ER stress by translocon opening in
the ER membrane, attracting proteins in the lumen and releasing calcium ions in the cytoplasm [65].
Moreover, also in PAN-treated podocytes, abnormal calcium flux, calpain, and calcineurin were
described [18]. GRP78 and GRP94 expression was detected in our study in PAN nephrotic rats,
which agrees with the findings that were reported by Inagi et al. [19]. However, TAU preconditioning
inhibited ER stress in nephrotic glomeruli and proximal tubules in line with previous studies on
cisplatin or starvation-triggered ER damage [66,67].
Another interesting novel finding of this study is the attenuation of ER stress driven by
pro-apoptotic CHOP and HSP25 in glomeruli and proximal tubules in PAN nephrotic rats pre-treated
with TAU. Although apoptosis and oxidative damage that was linked to ER stress in kidneys treated
with PAN have been well established [68,69], the beneficial role of TAU in nephritic kidney is still
unclear. However, TAU hampered ER and mitochondrial damage in neurodegeneration and stroke [70].
As podocytes are the main target of PAN toxin, proximal tubular cells may also be involved in the
reabsorption of excessive urinary proteins from the ultrafiltrate by unique transporters in their apical
site, called the brush border [38]. However, lysosomal cathepsins are also directly involved in acute
kidney disease progression [71]. Therefore, we analyzed cortical proximal tubules in PAN nephrotic
model while focusing on ER stress, apoptosis, and subcellular organelles changes in the lysosomes
and mitochondria. Intriguingly, our findings on the maintenance of cortical tubular dilatations in
PAN pre-treated with TAU mice agreed with those of Mozaffari et al. [72] who reported an apparent
detrimental role of TAU in rat kidney after ischemia-reperfusion.
Notably, we demonstrated that TAU antagonized tubular ER stress and apoptosis in nephrotic
animals. Moreover, TAU improved abnormal lysosomal accumulation, ER mitochondria tethering,
and mitochondrial integrity reducing HSP25 and GRP75 expressions. These findings highlighted
the preventive effect of TAU in subcellular sites essential for oxidative metabolism and calcium flux,
and that HSPs may be therapeutic targets [73,74]. In addition, the recovery of proper ER-mitochondria
tethering in TAU supplemented nephrotic rats suggested that TAU modulated bioenergetics [75]
or worked as a mitochondrial buffer of calcium in the nervous system, according to El Idrissi [76].
Furthermore, in MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like
episodes), which is a human mitochondrial disease with stroke-like episodes, TAU supplementation
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recovered mitochondrial respiratory function revealing a promising therapeutic role [43]. Finally,
we showed that oral TAU reduced tubular inflammation and caspase 1 activation in PAN nephrosis.
Recent studies reported that NOD-like receptor protein 3 (NLRP3) inflammasome was overloaded
with calreticulin in the ER in proximal tubular cells that were challenged with albumin [77]. ER stress
triggered a sterile inflammatory cascade, activating NLRP3 and caspase 1 in proteinuric patients [78].
Consequently, we hypothesized that dietary TAU supplementation, improving ER homeostasis, may be
able to limit the inflammatory reaction in proximal renal tubules, even if further experiments are
needed to verify this hypothesis.
5. Conclusions
Taken together, our results suggest that dietary TAU significantly preserves ER and mitochondria
features, promoting glomerular and tubular recovery and reducing experimental puromycin-induced
damage in rat kidney. Intriguingly, TAU decreased ER stress, and in parallel, mitochondria-related
apoptosis, drives mitochondria and ER expression of specific stress markers, hampering puromycin
nephrotic damage (Figure 7). This study reveals that CHOP may be an upstream therapeutic TAU
target able to drive downstream apoptosis triggered by ER and mitochondrial UPR in the puromycin
model [79]. Finally, this translational study implies that TAU might act as a potential promising
dietary additive in drug resistant-MCD patients. We only described the effective role of TAU in rat;
new studies on this potentiality should be completed in the future.
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